FR2721931B1 - CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES - Google Patents

CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES

Info

Publication number
FR2721931B1
FR2721931B1 FR9408096A FR9408096A FR2721931B1 FR 2721931 B1 FR2721931 B1 FR 2721931B1 FR 9408096 A FR9408096 A FR 9408096A FR 9408096 A FR9408096 A FR 9408096A FR 2721931 B1 FR2721931 B1 FR 2721931B1
Authority
FR
France
Prior art keywords
conjugates
diphosphate
immunoassay
enzymes
antigen proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9408096A
Other languages
French (fr)
Other versions
FR2721931A1 (en
Inventor
Charles Mioskowski
Jacques Grassi
Philippe Pradelles
Luc Lebeau
Mourad Saady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Commissariat a lEnergie Atomique CEA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9408096A priority Critical patent/FR2721931B1/en
Priority to PCT/FR1995/000872 priority patent/WO1996000585A1/en
Publication of FR2721931A1 publication Critical patent/FR2721931A1/en
Application granted granted Critical
Publication of FR2721931B1 publication Critical patent/FR2721931B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
FR9408096A 1994-06-30 1994-06-30 CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES Expired - Lifetime FR2721931B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9408096A FR2721931B1 (en) 1994-06-30 1994-06-30 CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES
PCT/FR1995/000872 WO1996000585A1 (en) 1994-06-30 1995-06-29 Diphosphate or triphosphate analogue conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408096A FR2721931B1 (en) 1994-06-30 1994-06-30 CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES

Publications (2)

Publication Number Publication Date
FR2721931A1 FR2721931A1 (en) 1996-01-05
FR2721931B1 true FR2721931B1 (en) 1996-08-02

Family

ID=9464857

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9408096A Expired - Lifetime FR2721931B1 (en) 1994-06-30 1994-06-30 CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES

Country Status (2)

Country Link
FR (1) FR2721931B1 (en)
WO (1) WO1996000585A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120707C (en) * 1995-11-22 2003-09-10 约翰斯·霍普金斯大学 Ligands to enhance cellular uptake of biomolecules
CN1113888C (en) 1996-10-09 2003-07-09 法玛塞特有限公司 Tetraphosphonate bicyclic trisanhydrides
EP1469003A3 (en) * 1996-10-09 2004-11-24 Pharmasset, Ltd. Tetraphosphonate bicyclic trisanhydrides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers

Also Published As

Publication number Publication date
WO1996000585A1 (en) 1996-01-11
FR2721931A1 (en) 1996-01-05

Similar Documents

Publication Publication Date Title
BR0112101A (en) Stabilized interleukin 2
IT1200382B (en) DETECTION AND / OR DOSAGE SYSTEM OF CLINICAL PARAMETERS BY IMMUNO ENZYMATIC ROUTE
SE8206168L (en) PEPTIDE PREPARATIONS
ATE135580T1 (en) THE USE OF AICA RIBOSIDE OR AICA RIBOTIDE FOR THE PREPARATION OF A MEDICAMENT AGAINST HEART ATTACK OR STROKE IN PATIENTS WITH ATHEROSCLEROSIS
DK0708772T3 (en) Imidazo [4,5-c] pyridin-4-amines
ES2091765T3 (en) DETECTION AND IDENTIFICATION PROCEDURE OF CONSTITUENTS CONTAINING NUCLEIC ACID.
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
FR2633182B1 (en) ANTI-CANCER PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE INVENTION
ATE92523T1 (en) METHODS FOR SEPARATION AND PURIFICATION OF SIALYL TRANSFER LASES.
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
EA200000196A1 (en) UNIVERSAL BLOOD PLASMA
DE69223952T2 (en) Design, construction and expression of chimeric proteins for the development of vaccines and diagnostic reagents
FR2721931B1 (en) CONJUGATES OF DIPHOSPHATE OR TRIPHOSPHATE ANALOGS WITH ENZYMES OR ANTIGEN PROTEINS AND IMMUNOASSAY USING SUCH CONJUGATES
DK0804228T3 (en) Drug containing the protein C activation peptide
DE3852625D1 (en) Vectors and compounds for the expression of zymogen forms of human protein C.
DK292584A (en) BIOLOGICAL ACTIVE CONJUGATES, THEIR PREPARATION AND USE
DK0535347T3 (en)
TNSN97173A1 (en) PEPTIDE ANALOGS OF LH-RH, THEIR USES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
DK319384A (en) 1-0-ALKYL-3-AMINO-PROPAN-1,2-DIOL-2-0-PHOSPHOLIPIDES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
EP0351790A3 (en) Method for the determination of fructosamine
ATE249837T1 (en) CASPASE 8 INHIBITORS FOR IMMUNOSUPRESSION
DK0674718T3 (en) Method for identifying individuals infected with HIV and monitoring their therapy
DK621688A (en) ETHYLERED AVERMECTINES AND PREPARATIONS CONTAINING THESE FOR THE TREATMENT AND PREVENTION OF HUMAN AND ANIMAL PARASITE INFECTIONS
FR2705233B1 (en) New dosage forms allowing differential timing of associations of micronutrients used in dietetics and / or therapeutics.
ES2113884T3 (en) USE OF ADENOSINE AND ADENOSINE DERIVATIVES USED IN ANESTHESIA PROCESSES.